PP1051P2
antibody from Acris Antibodies GmbH
Targeting: CCL4
Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PP1051P2 - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#PP1051P2, RRID:AB_1005276
- Product name
- anti MIP1 beta / CCL4
- Antibody type
- Polyclonal
- Antigen
- Highly pure (> 98%) E.coli derived recombinant Human MIP-1 beta (Cat.-No PA107)
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mg
Submitted references TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection.
Schlaepfer E, Audigé A, Joller H, Speck RF
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2888-95
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2888-95
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western Blot (Unreduced) using MIP1 beta / CCL4 Antibody Cat.-No PP1051P1
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western Blot (Reduced) using MIP1 beta / CCL4 Antibody Cat.-No PP1051P1
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Sandwich ELISA using MIP1 beta / CCL4 Antibody CAt.-No PP1051P
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunohistochemistry: This MIP1 beta antibody stained formalin-fixed, paraffin-embedded sections of human pancreas adenocarcinoma. The recommended concentration is 1.0 µg/ml with 2 hour incubation at room temperature. An HRP-labeled polymer detection system was used with a DAB chromogen. Heat induced antigen retrieval with a pH 6.0 sodium citrate buffer is recommended. Tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute.